Challenges and opportunities for therapeutic use of medical cannabis

被引:0
|
作者
Sampaio, M. F. S. [1 ,2 ]
Trancoso, I. [2 ,3 ]
Coimbra, N. C. [1 ]
Pereira, M. G. [2 ]
机构
[1] Univ Sao Paulo FMRP USP, Fac Med Ribeirao Preto, Dept Farmacol, Lab Neuroanat & Neuropsicobiol, Ribeirao Preto, SP, Brazil
[2] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, CCTA, Campos Dos Goytacazes, RJ, Brazil
[3] Canapse Assoc Canabiol Pesquisa & Serv, Marica, RJ, Brazil
来源
GENETICS AND MOLECULAR RESEARCH | 2024年 / 23卷 / 01期
基金
巴西圣保罗研究基金会;
关键词
Cannabis; Cannabinoids; Phytocannabinoids; Breeding cannabis; Therapeutic use; CHEMICAL PHENOTYPE; SATIVA L; INHERITANCE; EVOLUTION; GROWTH; PHYTOCANNABINOIDS; CULTIVATION; ENTOURAGE; HISTORY; THC;
D O I
10.4238/gmr19168
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Research has advanced and pre and post-harvest management strategies for Cannabis sativa have been proposed, aiming to improve cannabis production and efficiently attain industrial scale cannabinoid production. In general, studies have focused on genetic modification and cultivation methods designed to increase the content of the substance of interest (in general, cannabidiol; CBD) and obtain varieties with high productivity and resistance to pests. For the cannabis industry, propagating vigorous and uniform plants remains a challenge, as it is a dioecious crop and therefore depends on cross-fertilization for seed production. In this context, this review, through searches in international databases, examined aspects of the C. sativa plant associated with its genotypic plasticity and chemical variability, as well as strategies and perspectives for achieving success in industrial scale production of phytocannabinoids. The methods and techniques that have been used include micropropagation to generate exclusively female individuals; development of semi-dwarf cannabis cultivars, which have a high leaf density and low Delta(9)-Tetrahidrocanabinol (THC) levels; and alterations in the spectrum of LED lights to stimulate photoreceptors and maximize the yield and quality of cannabis, with reduced operational costs. Polyploidization has been used to develop new strains of cannabis with significant increases in CBD concentration in the terpene profile and in the buds of tetraploid clones, without increased THC content. Genetically modified microorganisms have been developed for large-scale production of both natural (phytocannabinoids) and non-natural cannabinoids. Parameters such as plant variety and density, light intensity, and fertilization affect biomass and cannabinoid yields. Considering the complexity of the endocannabinoid system and the specificities of the diseases that medicinal cannabis could be used to treat, obtaining a pharmaceutical product that meets this demand remains a great challenge.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Medical Education on Cannabis and Cannabinoids: Perspectives, Challenges, and Opportunities
    Ware, M. A.
    Ziemianski, D.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (06) : 548 - 550
  • [2] Cannabis: Innovation opportunities for its medical use
    Angulo-Cuentas, Gerardo
    Ramírez-Vergara, José
    Charris-Polo, Maryuris
    [J]. Recent Patents on Engineering, 2019, 13 (03) : 212 - 223
  • [3] Is the medical use of cannabis a therapeutic option for children?
    Rieder, Michael J.
    [J]. PAEDIATRICS & CHILD HEALTH, 2016, 21 (01) : 31 - 34
  • [4] The challenges and opportunities related to the therapeutic use of music in psychiatry
    Himmerich, Hubertus
    Heiderscheit, Annie
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024, 24 (07) : 615 - 618
  • [5] Therapeutic use of medical Cannabis in neurological diseases: a clinical update
    Hidding, Ute
    Mainka, Tina
    Buhmann, Carsten
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2024, 131 (02) : 117 - 126
  • [6] Therapeutic use of medical Cannabis in neurological diseases: a clinical update
    Ute Hidding
    Tina Mainka
    Carsten Buhmann
    [J]. Journal of Neural Transmission, 2024, 131 (2) : 117 - 126
  • [7] The Medical Director and the Use of Power: Limits, Challenges and Opportunities
    Gabel, Stewart
    [J]. PSYCHIATRIC QUARTERLY, 2011, 82 (03) : 221 - 228
  • [8] The Medical Director and the Use of Power: Limits, Challenges and Opportunities
    Stewart Gabel
    [J]. Psychiatric Quarterly, 2011, 82 : 221 - 228
  • [9] Therapeutic Benefits of Medical Cannabis
    Hajjar, Emily R.
    Lungen, Jessica M.
    Worster, Brooke K.
    [J]. PHYSICIAN ASSISTANT CLINICS, 2023, 8 (02) : 281 - 291
  • [10] Challenges and opportunities for further research involving the cannabis-to-opioid use transition
    Bahji, Anees
    Milloy, Michael John
    Bach, Paxton
    Socias, Maria Eugenia
    [J]. ADDICTION, 2022, 117 (10) : 2752 - 2754